Knockdown of TRIM8 alleviates dextran sulfate sodium-induced colitis in mice by inhibiting the NF-κB signaling pathway

Main Article Content

Ting Qiu
Yifei Lv
Lu Niu
Yu Zhang


inflammation, NF-κB, TRIM8, ulcerative colitis


Background: Although TRIpartite Motif containing 8 (TRIM8) gene plays an important role in a number of biological processes, such as inflammation, its function and mechanism in ulcerative colitis (UC) remain unknown.

Methods: The UC model was established by feeding mice with 3.5% dextran sulfate sodium (DSS). The animals were divided into the following four groups: control group, DSS group, DSS+short hairpin (sh)-NC group, and DSS+sh-TRIM8 group. Changes in body weight and disease activity index (DAI) score of mice in all the groups were recorded for 7 days. The animals were executed at the end of the experiment, and the expression of TRIM8 in colon tissue was detected by polymerase chain reaction and Western blot assays. The length of colon was measured, and the histopathological changes in mice colon were examined by hematoxylin and eosin staining. The expression of pro-inflammatory factors in mice serum and colonic tissue homogenate was detected by enzyme-linked-immunosorbent serologic assay. The expression of nuclear factor kappa B (NF-κB) pathway-related proteins in colonic tissues was detected by Western-blot analysis.

Results: TRIM8 was highly expressed in the colonic tissues of UC mice. Knockdown of TRIM8 improved DSS-induced weight loss, increased DAI score, shortened colon length, and alleviated colonic injury and inflammation in mice. Western-blot experiments showed that knockdown of TRIM8 inhibited DSS-induced phosphorylation of p65 and nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IκBα) protein but increased IκBα expression.

Conclusion: Knockdown of TRIM8 inhibits UC injury and inflammatory response caused by DSS. This could be related to the regulation of NF-κB signaling pathway by TRIM8 protein.

Abstract 82 | PDF Downloads 75 HTML Downloads 11 XML Downloads 2


1. Ding P, Liu J, Li Q, Lu Q, Li J, Shi R, et al. Investigation of the active ingredients and mechanism of hudi enteric-coated capsules in DSS-induced ulcerative colitis mice based on network pharmacology and experimental verification. Drug Design Dev Ther. 2021;15:4259–73. 10.2147/DDDT.S326029

2. Feng P, Li Q, Liu L, Wang S, Wu Z, Tao Y, et al. Crocetin prolongs recovery period of DSS-induced colitis via altering intestinal microbiome and increasing intestinal permeability. Int J Mol Sci. 2022;23(7):3832. 10.3390/ijms23073832.

3. Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am. 2020;49(4):643–54. 10.1016/j.gtc.2020.07.005

4. Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of “single protein RING finger” E3 ubiquitin ligases. BioEssays News Rev Mol Cell Dev Biol. 2005;27(11):1147–57. 10.1002/bies.20304

5. Caratozzolo MF, Marzano F, Mastropasqua F, Sbisà E, Tullo A. TRIM8: Making the right decision between the oncogene and tumour suppressor role. Genes (Basel). 2017;8(12):354. 10.3390/genes8120354.

6. Marzano F, Guerrini L, Pesole G, Sbisà E, Tullo A. Emerging roles of TRIM8 in health and disease. Cells. 2021;10(3):561. 10.3390/cells10030561

7. Tian Z, Tang J, Liao X, Gong Y, Yang Q, Wu Y, et al. TRIM8 inhibits breast cancer proliferation by regulating estrogen signaling. Am J Cancer Res. 2020;10(10):3440–57. 10.21203/

8. Marzano F, Caratozzolo MF, Pesole G, Sbisà E, Tullo A. TRIM proteins in colorectal cancer: TRIM8 as a promising therapeutic target in chemo resistance. Biomedicines. 2021;9(3):241. 10.3390/biomedicines9030241

9. Bai X, Zhang YL, Liu LN. Inhibition of TRIM8 restrains ischaemia-reperfusion-mediated cerebral injury by regulation of NF-κB activation associated inflammation and apoptosis. Exp Cell Res. 2020;388(2):111818. 10.1016/j.yexcr.2020.111818

10. Peng L, Gao X, Nie L, Xie J, Dai T, Shi C, et al. Astragalin attenuates dextran sulfate sodium (DSS)-induced acute experimental colitis by alleviating gut microbiota dysbiosis and inhibiting NF-κB activation in mice. Front Immunol. 2020;11:2058. 10.3389/fimmu.2020.02058

11. Lin JC, Wu JQ, Wang F, Tang FY, Sun J, Xu B, et al. Qing Bai decoction regulates intestinal permeability of dextran sulphate sodium-induced colitis through the modulation of notch and NF-κB signalling. Cell Prolif. 2019;52(2):e12547. 10.1111/cpr.12547

12. Shen J, Cheng J, Zhu S, Zhao J, Ye Q, Xu Y, et al. Regulating effect of baicalin on IKK/IKB/NF-kB signaling pathway and apoptosis-related proteins in rats with ulcerative colitis. Int Immunopharmacol. 2019;73:193–200. 10.1016/j.intimp.2019.04.052

13. Wei YY, Fan YM, Ga Y, Zhang YN, Han JC, Hao ZH. Shaoyao decoction attenuates DSS-induced ulcerative colitis, macrophage and NLRP3 inflammasome activation through the MKP1/NF-κB pathway. Phytomedicine Int J Phytother Phytopharmacol. 2021;92:153743. 10.1016/j.phymed.2021.153743

14. Zheng XY, Lv YF, Li S, Li Q, Zhang QN, Zhang XT, et al. Recombinant adeno-associated virus carrying thymosin β(4) suppresses experimental colitis in mice. World J Gastroenterol. 2017;23(2):242–55. 10.3748/wjg.v23.i2.242

15. He J, Song Y, Li G, Xiao P, Liu Y, Xue Y, et al. Fbxw7 increases CCL2/7 in CX3CR1hi macrophages to promote intestinal inflammation. J Clin Invest. 2019;129(9):3877–93. 10.1172/JCI123374

16. Peng Y, Yan Y, Wan P, Chen D, Ding Y, Ran L, et al. Gut microbiota modulation and anti-inflammatory properties of anthocyanins from the fruits of Lycium ruthenicum Murray in dextran sodium sulfate-induced colitis in mice. Free Radic Biol Med. 2019;136:96–108. 10.1016/j.freeradbiomed.2019.04.005

17. Rahmati M, Keshvari M, Xie W, Yang G, Jin H, Li H, et al. Resistance training and urtica dioica increase neurotrophin levels and improve cognitive function by increasing age in the hippocampus of rats. Biomed Pharmacother Biomed Pharmacother. 2022;153:113306. 10.1016/j.biopha.2022.113306

18. Li H, Fan C, Feng C, Wu Y, Lu H, He P, et al. Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity. Br J Pharmacol. 2019;176(13):2209–26. 10.1111/bph.14667

19. Qu Y, Li X, Xu F, Zhao S, Wu X, Wang Y, et al. Kaempferol alleviates murine experimental colitis by restoring gut microbiota and inhibiting the LPS-TLR4-NF-κB axis. Front Immunol. 2021;12:679897. 10.3389/fimmu.2021.679897

20. Rogler G. Chronic ulcerative colitis and colorectal cancer. Cancer Lett. 2014;345(2):235–41. 10.1016/j.canlet.2013.07.032

21. Peng X, Li J, Tan S, Xu M, Tao J, Jiang J, et al. COX-1/PGE(2)/EP4 alleviates mucosal injury by upregulating β-arr1-mediated Akt signaling in colitis. Sci Rep. 2017;7(1):1055. 10.1038/s41598-017-01169-6

22. Yan YX, Shao MJ, Qi Q, Xu YS, Yang XQ, Zhu FH, et al. Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages. Acta Pharmacol Sinica. 2018;39(10):1633–44. 10.1038/aps.2017.185

23. Ma J, Yin G, Lu Z, Xie P, Zhou H, Liu J, et al. Casticin prevents DSS-induced ulcerative colitis in mice through inhibitions of NF-κB pathway and ROS signaling. Phytother Res (PTR). 2018;32(9):1770–83. 10.1002/ptr.6108

24. Li XX, Chen SG, Yue GG, Kwok HF, Lee JK, Zheng T, et al. Natural flavone tricin exerted anti-inflammatory activity in macrophage via NF-κB pathway and ameliorated acute colitis in mice. Phytomed Int J Phytother Phytopharmacol. 2021;90:153625. 10.1016/j.phymed.2021.153625

25. Zhang X, Feng Y, Li J, Zheng L, Shao Y, Zhu F, et al. MicroRNA-665-3p attenuates oxygen-glucose deprivation-evoked microglial cell apoptosis and inflammatory response by inhibiting NF-κB signaling via targeting TRIM8. Int Immunopharmacol. 2020;85:106650. 10.1016/j.intimp.2020.106650